IL17A and myeloproliferative disorder: We identified CXCL8, CXCL10, IL-18, and CCL2 as MPN-associated soluble mediators; IL-17, IFN-γ, and HGF as biomarkers for PV; and CCL2 as biomarker for monitoring the BM fibrosis.